Similar articles

• Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.

  Bermudez LE, Wu M, Young LS, Inderlied CB. Bermudez LE, et al. J Infect Dis. 1992 Oct;166(4):923-6. doi: 10.1093/infdis/166.4.923. J Infect Dis. 1992. PMID: 1445599
• Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.

  Renvoisé A, Brossier F, Galati E, Veziris N, Sougakoff W, Aubry A, Robert J, Cambau E, Jarlier V, Bernard C. Renvoisé A, et al. Antimicrob Agents Chemother. 2015 Nov;59(11):7153-5. doi: 10.1128/AAC.01027-15. Epub 2015 Aug 31. Antimicrob Agents Chemother. 2015. PMID: 26324275 Free PMC article. No abstract available.
• Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages.

  Kesavalu L, Goldstein JA, Debs RJ, Düzgünes N, Gangadharam PR. Kesavalu L, et al. Tubercle. 1990 Sep;71(3):215-7. doi: 10.1016/0041-3879(90)90079-n. Tubercle. 1990. PMID: 2238129
• Susceptibility testing of Mycobacterium avium complex isolates.

  Heifets L. Heifets L. Antimicrob Agents Chemother. 1996 Aug;40(8):1759-67. doi: 10.1128/AAC.40.8.1759. Antimicrob Agents Chemother. 1996. PMID: 8843278 Free PMC article. Review. No abstract available.
• Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.

  Shirley M. Shirley M. Drugs. 2019 Apr;79(5):555-562. doi: 10.1007/s40265-019-01095-z. Drugs. 2019. PMID: 30877642 Free PMC article. Review.